Radiopharmaceutical Business Unit

The Radiopharmaceutical Business Unit has been exclusively focused on supplying radiopharmaceutical products to nuclear medicine professionals serving the recovery of patients worldwide and supporting early diagnosis.

Our effective Quality Management System is compliant with customer standards and regulatory requirements and ensures the high-quality of our products.

Our R&D group provides exceptional service in the development and manufacture of radiopharmaceuticals.

We are proud to be involved in various co-operations and partnerships benefiting from our specific expertise, technological background and well-equipped facility.

Cold kits with Tc-99m labelling for diagnosis

Cold kits with Tc-99m labelling for diagnosis

Cold kits for radiopharmaceutical preparation with sodium pertechnetate (Tc-99m) injection for diagnosis.

I-131 MIBG for therapy and diagnosis

I-131 MIBG for diagnosis and therapy

I-131 MIBG for diagnosis and therapy: I-131 MIBG 20 MBq/ml injection for diagnostic use – I-131 MIBG 370 MBq/ml injection for therapy

I-131 Drug substance

I-131 Drug substance

I-131 Drug substance: I-131 sodium iodide solutions, drug substances supported with Active Substance Master File

I-125 Radiochemicals

I-125 Radiochemicals

I-125 Radiochemicals: High purity I-125 sodium iodide solution for labelling


Composition of the MULTIBONE Kit – Composition of the Radioactive Precursor – Composition of the ‘On the Spot’ Prepared Injection

Cookies help us deliver our services. By using our services, you agree to our use of cookies. More Information